Tata India Pharma & Healthcare Fund - Direct Plan - Growth Option

Tata Mutual Fund · Sectoral/Thematic · Direct · Growth

NAV · as of 11/09/2026

39.24

-0.54%

+8.63%

Key stats

Expense ratio: 0.97%
AUM: ₹1.57 K Cr
Launched: 28/12/2015
Fund manager: Rajat Srivastava
Portfolio turnover: 1.04%
Risk: Very High Risk
Min lump-sum: ₹5,000
Min SIP: ₹100/mo
Fresh lump-sum: Accepted
Fresh SIP: Accepted

NAV history

Tata India Pharma & Healthcare Fund - Direct Plan - Growth Option

13/08/2026 to 11/09/2026

O - H - L -

1W-0.68%

1M-1.75%

3M+6.02%

6M+14.96%

1Y+8.63%

3Y+19.70%

5Y+14.60%

MAX+291.07%

Top holdings

41 disclosed

1.
Sun Pharmaceuticals Industries Ltd
Healthcare
8.59%
2.
Divi's Laboratories Ltd
Healthcare
6.36%
3.
HealthCare Global Enterprises Ltd
Healthcare
5.85%
4.
Abbott India Ltd
Healthcare
5.63%
5.
Rainbow Childrens Medicare Ltd
Healthcare
4.90%
6.
GlaxoSmithKline Pharmaceuticals Ltd
Healthcare
4.66%
7.
Cipla Ltd
Healthcare
4.53%
8.
Dr Reddy's Laboratories Ltd
Healthcare
4.25%
9.
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
4.07%
10.
Apollo Hospitals Enterprise Ltd
Healthcare
3.90%
11.
Bayer CropScience Ltd
Basic Materials
3.26%
12.
Fortis Healthcare Ltd
Healthcare
3.12%
13.
Pfizer Ltd
Healthcare
3.06%
14.
Mankind Pharma Ltd
Healthcare
3.02%
15.
Syngene International Ltd
Healthcare
2.95%
16.
Sai Life Sciences Ltd
Healthcare
2.89%
17.
Lupin Ltd
Healthcare
2.64%
18.
Alkem Laboratories Ltd
Healthcare
2.58%
19.
Procter & Gamble Health Ltd
Healthcare
2.42%
20.
FDC Ltd
Healthcare
2.39%
21.
Dr. Lal PathLabs Ltd
Healthcare
2.17%
22.
Global Health Ltd
Healthcare
2.13%
23.
Concord Biotech Ltd
Healthcare
1.91%
24.
Sumitomo Chemical India Ltd Ordinary Shares
Basic Materials
1.59%
25.
Ajanta Pharma Ltd
Healthcare
1.53%
26.
Neuland Laboratories Ltd
Healthcare
1.25%
27.
Gillette India Ltd
Consumer Defensive
1.15%
28.
Metropolis Healthcare Ltd
Healthcare
1.12%
29.
Manipal Health Enterprises Ltd
Healthcare
0.97%
30.
BASF India Ltd
Basic Materials
0.97%
31.
Jubilant Pharmova Ltd
Healthcare
0.83%
32.
Dr Agarwal’s Health Care Ltd
Healthcare
0.67%
33.
Cash / Net Current Asset
0.60%
34.
Sanofi Consumer Healthcare India Ltd
Healthcare
0.55%
35.
Biocon Ltd
Healthcare
0.52%
36.
Zim Laboratories Ltd Ordinary Shares
Healthcare
0.46%
37.
(I) Treps
0.26%
38.
Sanofi India Ltd
Healthcare
0.23%
39.
Anthem Biosciences Ltd
Healthcare
0.01%
40.
Ipca Laboratories Ltd
-
41.
Torrent Pharmaceuticals Ltd
-

Sector allocation

Healthcare92.17%
Basic Materials5.82%
Consumer Defensive1.15%
Unclassified0.86%

Comparable peers

SBI Healthcare Opportunities Growth Direct Plan
SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM
1Y+22.13%
3Y+24.61%
-
Mirae Asset Healthcare Growth Direct Plan
Mirae Healthcare (G) · ₹3.44 K Cr AUM
1Y+20.35%
3Y+23.20%
-
UTI Healthcare Growth Direct Plan
UTI Healthcare (G) · ₹1.44 K Cr AUM
1Y+17.28%
3Y+24.42%
-
HDFC Transportation & Logistics Growth Direct Plan
HDFC Transportation & Logistics (G) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-
Tata India Pharma & Healthcare Growth Direct Plan
Tata India Pharma & Healthcare (G) · ₹1.57 K Cr AUM
1Y+9.47%
3Y+20.00%
-

Investment objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Scheme details

Scheme code: 135810
Fund house: Tata Mutual Fund
Category: Open Ended
Type: Equity Scheme
Sub-category: Sectoral/Thematic
Plan: Direct
Return type: Growth
ISIN (Growth): INF277K019A3
ISIN (Div. Reinvest): -
Tradable on exchange: No

Kuvera page